The Economic Standard is proud to present our first white paper. We demonstrate through meticulously sourced analysis: 1) Hydroxychloroquine (HCQ) is a safe, versatile medicine that has treated hundreds of millions of people for many diseases over seven decades. 2) Numerous controlled observational studies and meta-analyses have demonstrated that HCQ can help […]
Tag: HCQ
Putting Trump’s Treatment in Context
By Erik Sass, TES Editor-in-Chief On May 18, President Trump announced that he began taking a combination of hydroxychloroquine (HCQ), azithromycin, and zinc about 10 days prior. This was around the same time that multiple White House staffers were reported to have contracted the novel coronavirus. The President appears to be taking this […]
Why was positive HCQ data removed from draft of BMJ paper?
On May 14, the British Medical Journal published an article presenting the results of a multi-center trial of hydroxychloroquine (HCQ) in Chinese patients with COVID-19 in February. It concluded: “Administration of hydroxychloroquine did not result in a significantly higher probability of negative conversion than standard of care alone in patients admitted to hospital […]